Higher risk of death from skin cancer among men living alone
4/02/2014

There are differences in prognosis in cutaneous malignant melanoma depending on cohabitation status and gender, according to a new study published in the scientific periodical Journal of Clinical Oncology. Single men of all ages are more likely to die of their disease.Cutaneous malignant melanoma is the most aggressive form of skin cancer.

New role discovered for enzyme could have implications for cancer and neurologic disease
4/02/2014

Research from Rutgers Cancer Institute of New Jersey shows that a new function discovered for a long-studied enzyme could have implications for the diagnosis and treatment of some cancers and neurological disease.

European commercial launch of first approved life-saving treatment for severe hepatic veno-occlusive disease
4/02/2014

Jazz Pharmaceuticals plc and Gentium S.p.A., a Jazz Pharmaceuticals company, have announced the commencement of the European commercial launch of Defitelio®q (defibrotide), the first licensed product for the treatment of severe hepatic veno-occlusive disease (severe VOD or sVOD) in patients over one month of age undergoing haematopoietic stem cell transplantation (HSCT) therapy.

Administering blood transfusions to patients with lower levels of hemoglobin associated with lower risk of serious infection
4/02/2014

Restricting red blood cell (RBC) transfusions among hospitalized patients to those with hemoglobin (the iron-containing protein in RBCs) measures below a certain level is associated with a lower risk of health care-associated infections, according to a study in JAMA. Efforts to prevent health care-associated infection are among the priorities for the U.S.

Schizophrenia reversed in adolescent mice by experimental cancer drug
4/02/2014

Johns Hopkins researchers say that an experimental anticancer compound appears to have reversed behaviors associated with schizophrenia and restored some lost brain cell function in adolescent mice with a rodent version of the devastating mental illness.

Latest findings reveal the genomic landscape of oesophageal squamous carcinoma
4/02/2014

A team of scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore and National University Cancer Institute Singapore (NCIS), and their collaborators from the Cedars-Sinai Medical Centre, UCLA School of Medicine, demonstrated that a number of novel genetic defects are able to induce oesophageal cancer.

Postsurgery neurofunctional outcome in pediatric spinal tumor improved by early rehabilitation
4/02/2014

In children, primary spinal tumors comprise 4% of all tumors from the central nervous system. Spinal tumors can present with a variety of clinical signs and symptoms in children such as pain followed by motor regression, gait disturbance, sphincter dysfunction, sensory symptoms, torticollis, and kyphoscoliosis.

Baker's yeast analyzed to discover potential for combating neurological conditions like Parkinson's, cancer
4/02/2014

A humble ingredient of bread - baker's yeast - has provided scientists with remarkable new insights into understanding basic processes likely involved in diseases such as Parkinson's and cancer.

Pre-cancerous breast cancer cells treated with a vitamin A derivative revert into non-cancerous cells
4/02/2014

A derivative of vitamin A, known as retinoic acid, found abundantly in sweet potato and carrots, helps turn pre-cancer cells back to normal healthy breast cells, according to research published this month in the International Journal of Oncology.

Breast cancer origins study paves way for personalized treatment
4/02/2014

Breast cancers can look and behave very differently. Understanding why and how they do so is key to designing more tailored therapies for patients and sparing them unnecessary treatments.In a new study published by the Journal of Pathology, Dr Matt Smalley from Cardiff University treads new ground in exploring what drives breast cancers to look and behave so differently from one another.